Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treat_CCM: Propranolol in Familial Cerebral Cavernous Malformation
NCT03589014Phase 2Completed
- Sponsor
- Mario Negri Institute for Pharmacological Research
- Start
- Apr 2018
- Primary completion
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of propranolol in familial cerebral cavernous malformation (CCM), sponsored by Mario Negri Institute for Pharmacological Research. Started Apr 2018; status: completed.
02
Drugs
propranolol
03
Conditions
familial cerebral cavernous malformation (CCM)
Beyond the preview
Go deeper on NCT03589014.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03589014.